CPCS: A Model for Strategic Leadership in Long COVID Care and Research
In the recent Nature Medicine article titled "Long COVID science, research and policy", the authors emphasise the critical need for establishing dedicated professional societies at both national and global levels to address the unique challenges posed by Long COVID. The article points out that Long COVID, due to its multisystemic nature, doesn't align neatly with traditional, organ-specific medical structures. As such, there is a growing need for professional "homes" that can provide the necessary strategic leadership, coordination, and advocacy for this complex condition.
These professional societies are envisioned as central hubs that would guide the clinical management of Long COVID and related conditions. They would play a pivotal role in organizing national and international conferences, facilitating research, and synthesizing evidence into actionable guidelines for healthcare providers. By coordinating education and research efforts, these societies would help ensure that the medical community stays informed and equipped to handle the ongoing challenges of Long COVID.
The article specifically highlights the Clinical Post COVID Society (CPCS) as a promising example of what such a professional society can achieve. The CPCS provides opportunities for networking and strategic leadership in the clinical management of Long COVID for both adults and younger populations. It boasts a diverse, multidisciplinary clinical leadership team, reflecting the varied expertise needed to care for patients with Long COVID.
Moreover, the society is actively involved in developing position papers on best practices, linking them with guidelines from key stakeholders like the National Institute for Health and Care Excellence (NICE). It also plans to host national and international courses and conferences, offering educational and training packages for clinicians. In addition, the society will undertake service evaluation projects and collaborates with academics and individuals with lived experience to facilitate research, contributing to a deeper understanding of Long COVID and improving patient care.
The establishment of similar societies around the world, as advocated by the Nature Medicine article, could lead to a more coordinated and effective response to Long COVID, enhancing care standards and driving global research efforts to improve outcomes for those affected.